SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Conversation is dominated by intense political polarization and negative sentiment, focusing on recent campaign promises of a $5,000 dividend, accusations of government corruption, and heated debates over economic policies and international conflicts. Traders are expressing significant disagreement, with many characterizing the stock's performance and the company's leadership as a scam or failing venture.

VeChain is a public Layer-1 blockchain designed for real-world applications. Founded in 2015, its VeChainThor network supports enterprise and consumer use cases involving supply chains, product provenance, sustainability, digital product passports, tokenized incentives and verifiable data.  VeChainThor combines EVM-compatible smart contracts with a dual-token model, native fee delegation and multi-clause transactions. VET is the network’s native asset and staking collateral, while VTHO is used to pay transaction fees and execute smart contracts.  VeChain’s ecosystem includes VeBetter, an app platform that rewards verified positive actions; StarGate, its NFT-based staking platform; VeWorld, its self-custody wallet; and VeWorld.ai, its AI-agent platform. In its April 2026 roadmap, VeChain reported that VeBetter had reached 5.3 million users, more than 50 live applications and over 50 million verified actions.  VeChain has also worked with organizations including Walmart China, DNV, PwC, Boston Consulting Group and UFC across enterprise, sustainability and consumer initiatives.

Vechain

VeChain is receiving attention amid significant community frustration over prolonged downward price action and declining market rank, with many traders expressing skepticism regarding the project's long-term viability. While some investors continue to accumulate the token in anticipation of future protocol upgrades and potential enterprise adoption, sentiment is largely divided between bullish long-term holders and vocal critics who view the asset as a failing investment.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The software sector is trending due to persistent rotation out of semiconductors and AI hardware, with traders debating whether this shift represents a sustainable recovery from the "SaaSpocalypse" or merely unstable sector hopping. While some market participants see an opportunity to buy beaten-down software stocks as enterprise AI monetization strengthens, others warn that volatility remains high and caution that semiconductors could reclaim leadership if infrastructure spending remains robust.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp is trending as traders debate the implications of a recent S-3ASR filing, with many clarifying that it is a routine shelf registration for future financing flexibility rather than an immediate share offering or dilution event. While some investors expressed concerns over potential selling pressure, others pointed to the company's ongoing share buyback program and strong fundamental position as reasons to maintain a long-term bullish outlook.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

The conversation is dominated by frustration regarding recent downward price movement and a lack of near-term catalysts, though long-term investors remain optimistic about the growth potential of the Recorlev franchise and the upcoming XP-8121 Phase 3 trial. Some traders express concern over the stock's stagnant performance compared to the broader biotech sector, while others argue the company is fundamentally undervalued and accumulating shares during this period of consolidation.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival Corp is experiencing significant price volatility driven by market sensitivity to fluctuating crude oil prices and geopolitical tensions surrounding the Strait of Hormuz. Traders are divided, with many viewing the current price as a buying opportunity based on strong company fundamentals and share buybacks, while others express frustration over the stock's performance being heavily influenced by external macro factors.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending following the company's decision to upsize its share repurchase program by $200 million, bringing the total authorized buyback to $500 million. Traders are actively debating whether this move signals long-term confidence and undervaluation or is a tactical effort to support the stock price ahead of a potential future relisting.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following mixed reactions to the IZAR-1 Phase 3 trial results, where the drug met its primary endpoints but disappointed traders seeking a blowout Best-in-Class profile. Community discussion is currently dominated by concerns over potential dilution from a new mixed shelf offering, though some investors remain bullish, citing strong cash reserves and upcoming catalysts like the BLA submission for its lead asset.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending following its recent fiscal first-quarter earnings report, which featured a revenue and earnings beat alongside record backlog growth. While many traders highlight the company's strong performance and new contract wins, others express disappointment that the stock did not see a stronger positive reaction and remain concerned about guidance and broader market sentiment toward the defense sector.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is trending as traders debate the market's trajectory amid rising Treasury yields, spiking oil prices, and uncertainty surrounding upcoming inflation data. Sentiment is divided between bulls betting on continued market resilience and bears warning of a potential correction driven by persistent macroeconomic pressures and political uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.

Citius Oncology Inc.

Bullish Sentiment

Yes, day one

Yes, but I'll wait for reviews

No, too expensive

No, not interested in a foldable

Apple unveiled its first foldable iPhone, reportedly called the iPhone Duo, at its September 9 event, with pricing starting at $2,000 for the 256GB model. Will you buy the $2,000 iPhone Duo? Vote and explain your reasoning in the comments.

Apple ($AAPL) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Stocktwits

Apple Inc

) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Feed

News

Sentiment

Fundamentals

Info

TENK TenX Keane Acquisition

Fundamentals

Latest TENK News